Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Consumer News Experimental Drug Helped Alzheimer S Patients In Small Trial

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Experimental Drug Helped Alzheimer S Patients In Small Trial is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Consumer News Experimental Drug Helped Alzheimer S Patients In Small Trial | RobinsPost News & Noticias

Alzheimer’s pill could reduce brain decline in some high-risk patients, trial suggests


An experimental pill could slow memory loss and brain shrinkage in some Alzheimer’s patients, new research suggests. The pill, called ALZ-801 (valiltramiprosate), was shown to be effective in people ... Read More

Shingles vaccine most promising common drug to potentially prevent Alzheimer’s – research


A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer’s disease. Read More

The surprising drugs that could be used to halt Alzheimer’s


Study found drugs used to prevent shingles and treat erectile dysfunction could be promising for Alzheimer’s patients ... Read More

New trial finds two commonly available drugs may delay Alzheimer’s


Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found. These findings can address a critical treatment gap for patients with ... Read More

Cognition Therapeutics Completes Enrollment in Phase 2 Study of Zervimesine (CT1812) in Early Alzheimer’s Disease


Study conducted in collaboration with the Alzheimer’s Clinical Trials ConsortiumPURCHASE, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus